Commons Sense

House of Commons · Written Ministerial Statement

Covid-19 Update

12 January 2022 · Department of Health and Social Care

Proposed by Sajid Javid Con Bromsgrove

NHS

Summarised by AI from the official record, so it can contain mistakes.

View on Parliament.uk

At a glance

Key points

  • The PANORAMIC study evaluates new antivirals against COVID-19, with a focus on molnupiravir.
  • MPs are asked to encourage constituents to join the PANORAMIC trial via the website or freephone number.
  • Further updates will be published by the Department as additional data is gathered.

Issue summary

The statement provides an update on the progress of the PANORAMIC study for evaluating new antivirals against COVID-19, particularly focusing on molnupiravir.

Action requested

MPs are requested to encourage their constituents to participate in the PANORAMIC trial by signing up online or through a freephone number. The Department will publish further updates as more data becomes available.

Key facts

  • The PANORAMIC study was launched on 8 December 2021.
  • Recruitment of 3,176 participants has been achieved as of noon on 12 January 2022.
  • Participants must be over 50 years old or over 18 with certain underlying health conditions and have received a positive test for COVID-19 within the last five days.
  • Molnupiravir was granted conditional Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency on 4 November 2021.
▸ Assessment & feedback
Summary accuracy